Drug profile · INN
insulin degludec / insulin aspart
RYZODEG
insulin degludec / insulin aspart (RYZODEG) is an FDA-listed pharmaceutical active ingredient.
PMDA: approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — insulin degludec / insulin aspart
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.78
Quick answer
insulin degludec / insulin aspart (RYZODEG) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN insulin degludec / insulin aspart
Brand RYZODEG
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Pipeline programs
Frequently asked questions
What is insulin degludec / insulin aspart?
insulin degludec / insulin aspart (RYZODEG) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for insulin degludec / insulin aspart?
RYZODEG is a marketed brand name for insulin degludec / insulin aspart. Check FDA Drugs@FDA for the current US label holder and prescribing information.